Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL; NORDIC Idiopathic Intracranial Hypertension Study Group.

Invest Ophthalmol Vis Sci. 2016 Mar;57(3):805-12. doi: 10.1167/iovs.15-18626.

2.

Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension.

Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, Patel AD, Bruce BB, He H, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group.

Neurology. 2015 Sep 1;85(9):799-805. doi: 10.1212/WNL.0000000000001896. Epub 2015 Aug 5.

3.

Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.

OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith MJ, Sibony P, Plumb K, Wang JK, Werner JS.

Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8173-9. doi: 10.1167/iovs.14-14961.

4.

Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.

OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS.

Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8180-8. doi: 10.1167/iovs.14-14960. Erratum in: Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6909.

5.

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ.

JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312.

6.

The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group.

JAMA Neurol. 2014 Jun;71(6):693-701. doi: 10.1001/jamaneurol.2014.133.

7.

The idiopathic intracranial hypertension treatment trial: design considerations and methods.

Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL, Feldon SE, Schron E, Corbett JJ, Wall M; NORDIC IIHTT Study Group.

J Neuroophthalmol. 2014 Jun;34(2):107-17. doi: 10.1097/WNO.0000000000000114.

PMID:
24739993
8.

Complex shaped detachable platinum coil system for the treatment of cerebral aneurysms: the Codman Trufill DCS and Trufill DCS Orbit Detachable Coil System COMPLEX Registry final results.

Bendok BR, Rahme RJ; Complex Registry Group.

J Neurointerv Surg. 2013 Jan 1;5(1):54-61. doi: 10.1136/neurintsurg-2011-010118. Epub 2011 Nov 4.

PMID:
22058182
9.

Intraarterial therapy for acute ischemic strokes.

Belisle JG, McCollom VE, Tytle TL, Banowetz JM, Handley RA, Andrezik JA, Griggs TS.

J Vasc Interv Radiol. 2009 Mar;20(3):327-33. doi: 10.1016/j.jvir.2008.11.021. Epub 2009 Jan 21. Erratum in: J Vasc Interv Radiol. 2010 Apr;21(4):596.

PMID:
19157897
11.

Fenestrated basilar artery associated with multiple aneurysms.

Li W, Li M, Daniel HG, Wu DH, Tytle TL, Karatas R, Karatas Y, Yuh WT.

J Huazhong Univ Sci Technolog Med Sci. 2003;23(4):418-9, 426. No abstract available.

PMID:
15015651
12.

Non-surgical therapy of primary hyperparathyroidism.

Howell P, Kariampuzha S, Kipgen W, Baker MZ, Tytle TL, Williams GR, Scofield RH.

J Okla State Med Assoc. 2001 Dec;94(12):561-5.

PMID:
11775385
13.

Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility.

Birdwell BG, Raskob GE, Whitsett TL, Durica SS, Comp PC, George JN, Tytle TL, Owen WL, McKee PA.

Arch Intern Med. 2000 Feb 14;160(3):309-13.

PMID:
10668832
14.

The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis.

Birdwell BG, Raskob GE, Whitsett TL, Durica SS, Comp PC, George JN, Tytle TL, McKee PA.

Ann Intern Med. 1998 Jan 1;128(1):1-7.

PMID:
9424975
15.

A prospective, parallel, double-blind comparison of iodixanol and iohexol in extremity phlebography.

Tytle T, Prati RC Jr, Azodo MV, Gutierrez O.

Acad Radiol. 1996 Sep;3 Suppl 3:S519-23.

PMID:
8883531
16.

The role of radiology in the Oklahoma City bombing.

Nye PJ, Tytle TL, Jarman RN, Eaton BG.

Radiology. 1996 Aug;200(2):541-3.

PMID:
8685354
17.

Fistula between a posterior communicating artery aneurysm and the cavernous sinus.

Tytle TL, Loeffler CL, Steinberg TA.

AJNR Am J Neuroradiol. 1995 Oct;16(9):1808-10.

18.

Role of vascular and interventional radiology in the Oklahoma City bombing.

Tytle TL, Nye PJ.

J Vasc Interv Radiol. 1995 Sep-Oct;6(5):827-8. No abstract available.

PMID:
8541692
19.

The 'gooseneck' concept in microvascular retrieval.

Tytle TL, Prati RC Jr, McCormack ST.

AJNR Am J Neuroradiol. 1995 Aug;16(7):1469-71. No abstract available.

20.

Percutaneous recanalization in chronic occlusion of the superior mesenteric artery.

Tytle TL, Prati RC Jr.

J Vasc Interv Radiol. 1995 Jan-Feb;6(1):133-6. No abstract available.

PMID:
7703579

Supplemental Content

Loading ...
Support Center